CUX2
protein-codingcut like homeobox 2, the group of MicroRNA protein coding host genes|CUT class homeoboxes and pseudogenes
Gene summary
This gene encodes a protein which contains three CUT domains and a homeodomain; both domains are DNA-binding motifs. A similar gene, whose gene product possesses different DNA-binding activities, is located on chromosome on chromosome 7. Two pseudogenes of this gene have been identified on chromosomes 10 and 4. [provided by RefSeq, Jan 2013]
- CUTL2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~316.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0100062
Submitter: ClinGen
*CUX2* was first reported in relation to autosomal dominant developmental and epileptic encephalopathy (DEE) in 2012 (Rauch et al., PMID: 23020937). The typical clinical presentation includes intellectual disability and seizure onset in the first year of life, sometimes associated with movement disorders, autism, hypotonia, and abnormal brain MRI (PMID: 29630738). Some individuals were reported to have a Rett-like phenotype including stereotypic movements, breathing abnormalities, and sleep disruption (PMID: 29630738). A recurrent de novo missense variant (c.1768G>A, p.Glu590Lys) accounts for the majority of published variants in this gene and has been identified in at least 11 probands in four publications (PMIDs: 29630738, 23020937, 29795476, 30842224). Other missense variants (p.Thr642Met and p.Arg1458Gln) were given zero points due to a lack of detailed clinical information and presence of the variants in gnomAD (PMIDs: 31785789, 35571021). Finally, a de-novo p.Thr945Met missense variant was identified in a patient with a history of three febrile seizures, intellectual disability, and developmental delay. It was not scored at this time due to the proband’s milder phenotypic presentation and uncertainty about the association of variants other than p.Glu590Lys with DEE (PMID: 35846140).The mechanism of pathogenicity is currently unknown and there is no experimental evidence available at this time. In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Epilepsy Gene Curation Expert Panel on the meeting date May 16, 2023 (SOP Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0029138
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0029138
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0016532
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0029138
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CUX2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015267.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 103 | 2 | 107 | ||
| missense | 1 | 2 | 312 | 86 | 3 | 404 |
| nonsense | 5 | 5 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 7 | 8 | |||
| splice donor/acceptor (+/-2bp) | 4 | 1 | 5 | |||
| Total | 1 | 3 | 330 | 190 | 5 | 529 |
Highest pathogenic variant AF is 6.2467984e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056082.2 | 22 | MANE Select | |
| Ensembl | ENSP00000261726.6 | 22 | MANE Select | |
| RefSeq | NP_001357527.1 | 20 | Standard | |
| Ensembl | ENSP00000380765.3 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- negative regulation of transcription by RNA polymerase II
- short-term memory
- positive regulation of gene expression
- Golgi vesicle transport
- positive regulation of dendrite morphogenesis
Molecular Function
- RNA polymerase II regulatory region sequence-specific DNA binding
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- sequence-specific DNA binding
Cellular Component
- Golgi membrane
- nucleus
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000261726
- Coding exons
- 22
- Length
- 316531
- Individuals with no LoFs
- 124785
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 9
- Defined
- 124794
- p
- 0.0000361
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.18 | 615 | 881 | 0.698 | 0.0000575 | 9418 |
| Missense (PolyPhen) | 161 | 324.11 | 0.49675 | 3372 | ||
| Synonymous | 1.62 | 365 | 407 | 0.898 | 0.0000292 | 3110 |
| Loss of Function | 6.67 | 6 | 63.2 | 0.0949 | 0.00000305 | 753 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00020 | 0.00013 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000048 | 0.000046 | rare |
| European (Non-Finnish) | 0.000046 | 0.000044 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be a transcription factor involved in neural specification. Binds to DNA in a sequence-specific manner (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- LoFtool
- 0.280
- RVIS EVS
- -2.08
- RVIS percentile EVS
- 1.6
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.227
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |